section name header

Basics

Description
Epidemiology

Incidence

  • US: 2–14 cases per 100,000 (1)
  • Bimodal distribution with diagnosis peaking between ages 15 25 then in the 50s

Prevalence

More common in females (2)

Morbidity

  • The ultimate cure is colectomy
  • Patients suffer from flare-ups that can cause significant discomfort weight loss.

Mortality

Low, but there is an increased rate of colorectal cancers.

Etiology/Risk Factors
Physiology/Pathophysiology
Anesthetic GOALS/GUIDING Principles

Diagnosis

Symptoms

History

  • Severity of chronic condition
  • Recent acute flares
  • Co-morbidities complications of therapy such as diabetes hypertension from chronic steroid use.

Signs/Physical Exam

  • Signs of dehydration: Decreased skin turgor, capillary refill, urinary output, blood pressure as well as tachycardia
  • Signs of electrolyte abnormalities: Muscle weakness
  • Malnutrition vitamin deficiencies
  • Painful lower extremity swelling may indicate a deep venous thrombosis (increased risk); shortness of breath may indicate a pulmonary embolus
Treatment History
Medications
Diagnostic Tests & Interpretation

Labs/Studies

  • Complete blood count to assess for anemia hemoconcentration
  • Complete metabolic panel (electrolytes LFTs). BUN/Cr ratio of 20:1 may indicate dehydration, low bicarbonate values may indicate acidosis due to dehydration or infection.
  • Coagulation studies if liver disease is present
  • EKG
  • Type screen or type cross if anemia is present
CONCOMITANT ORGAN DYSFUNCTION

Extra-intestinal manifestations:

Circumstances to delay/Conditions
Classifications

Treatment

PREOPERATIVE PREPARATION

Premedications

  • Anxiolysis as needed
  • Stress dose steroids should be considered if the patient has been treated for more than 2 weeks within the past 6–12 months to avoid manifestations of adrenal insufficiency. Steroids with glucocorticoid mineralocorticoid activity should be administered.
INTRAOPERATIVE CARE

Choice of Anesthesia

  • Epidurals for intraoperative (with or without GA) postoperative management should be considered for abdominal procedures. However, neuraxial blocks may be precluded with coagulopathy.

Monitors

  • Stard ASA monitors
  • Avoid rectal temperature monitoring
  • Foley catheter in long cases, suspected hypovolemia, or anticipated large fluid shifts
  • Arterial line may be considered in patients who are anemic, have baseline electrolyte abnormalities, brittle diabetes (from steroid use), or if the surgical procedure is anticipated to yield large blood loss.
  • Consider a central venous catheter for pressure monitoring guidance on fluid resuscitation.

Induction/Airway Management

  • In hypovolemic patients, consider adequate preoperative fluid hydration prior to induction.
  • Etomidate or ketamine can be useful in hypovolemic patients; have vasopressors available.
  • In anemic patients, consider having blood available or transfuse prior to induction.

Maintenance

  • Muscle relaxation can aid surgical exposure closure of abdominal fascia for bowel surgery.
  • Fluid management: Replace deficits with crystalloid. Be aware of replete insensible losses. Patients are at risk for significant third-spacing bowel edema, especially due to low colloid oncotic pressures. This can make closure of abdominal incisions more difficult.
  • Low albumin levels due to malnutrition: Adjust medication doses appropriately, particularly with highly protein-bound drugs. Unbound, free drug is pharmacologically active, is also available for metabolism. Thus consider smaller boluses more frequent dosing. Additionally, hypoalbuminemia may result in increased total body water volume of distribution for hydrophilic drugs.
  • Consider avoiding nitrous oxide for bowel surgery as it can cause the bowel to exp make fascial closure more difficult.
  • Diabetics may require intraoperative glucose management with insulin.
  • Intractable intraoperative hypotension may be due to adrenal insufficiency; treat with stress dose steroids.
  • Eye protection to avoid worsening ocular manifestations
  • Skin may be thin or easily breached from long-term steroid use; caution with positioning tape for IV sites, ETT, eyes

Extubation/Emergence

Reversal of nondepolarizing muscle relaxants can help minimize weakness as patients often have underlying weakness due to malnutrition electrolyte disturbances.

Follow-Up

Bed Acuity

Telemetry if the patient has severe electrolyte derangements

Medications/Lab Studies/Consults
Complications

References

  1. Loftus EV Jr . Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, environmental influences. Gastroenterology. 2004;126(6):15041517.
  2. Kappelman MD , Rifas-Shiman SL , Kleinman K , et al. The prevalence geographic distribution of Crohn's disease ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5(12):14241429.
  3. Abraham C , Cho JH. Inflammatory bowel disease. N Eng J Med. 2009:361(21):20662078.
  4. Baumgart DC , Carding SR. Inflammatory bowel disease: cause immunobiology. Lancet. 2007; 369(9573):16271640.

Additional Reading

See Also (Topic, Algorithm, Electronic Media Element)

Codes

ICD9
ICD10

Clinical Pearls

Author(s)

rea Parsons , MD